Table 1.

Patient characteristics

Patient	Initially			Baseline			Follow-up
	Sex	Age	Affected side	H and Y	UPDRS	Med. a	H and Y	UPDRS	Med. a
1	M	63	L	1	5	2	2	16	1, 2, 4
2	M	57	L	1	4.5	1, 2	2	8	4
3	M	49	R	1.5	10	1, 2, 3, 4	2	13	1, 2, 6
4	M	33	L	1	12	None	3	40	1, 4, 6
5	M	60	L	1	9	None	2.5	20	4
6	M	52	R	1	8	None	1.5	7	4
7	M	53	R	1	6	None	2	12	None
8	F	58	L	1.5	3	1, 2	2.5	11	Missing data
9	F	67	R	1.5	15	None	2.5	17	4
10	M	70	R	1	2	1	2.5	8	1, 4
11	M	70	R	1.5	19	None	2	22	1, 5
12	F	65	L	1	11.5	4	2	12	4
13	M	62	R	1	5	None	2	15	4

^aMedication key: 1=levodopa; 2=deprenyl; 3=anticholinergics; 4=dopamine agonists; 5=amantadine; 6=COMT inhibitor.